Published in Heart Fail Rev on December 01, 2007
S-nitrosylation in cardiovascular signaling. Circ Res (2010) 3.02
S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell (2008) 1.63
Protein S-nitrosylation and cardioprotection. Circ Res (2010) 1.63
A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2009) 1.33
Estrogen Regulation of MicroRNA Expression. Curr Genomics (2009) 1.20
Cytoprotection by the modulation of mitochondrial electron transport chain: the emerging role of mitochondrial STAT3. Mitochondrion (2011) 1.17
Myocardial protection by nitrite. Cardiovasc Res (2009) 1.16
Estrogen, aging and the cardiovascular system. Future Cardiol (2009) 1.09
Influence of sex hormones and phytoestrogens on heart disease in men and women. Womens Health (Lond Engl) (2010) 1.02
Oxysterols and their cellular effectors. Biomolecules (2012) 0.92
Caveolin and proteasome in tocotrienol mediated myocardial protection. Cell Physiol Biochem (2008) 0.88
Isolating the segment of the mitochondrial electron transport chain responsible for mitochondrial damage during cardiac ischemia. Biochem Biophys Res Commun (2010) 0.87
Tetrahydrobiopterin restores diastolic function and attenuates superoxide production in ovariectomized mRen2.Lewis rats. Endocrinology (2011) 0.86
miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1. Physiol Genomics (2013) 0.84
Mitochondrial p38β and manganese superoxide dismutase interaction mediated by estrogen in cardiomyocytes. PLoS One (2014) 0.83
The Importance of Biological Sex and Estrogen in Rodent Models of Cardiovascular Health and Disease. Circ Res (2016) 0.82
Glutathione peroxidase deficiency exacerbates ischemia-reperfusion injury in male but not female myocardium: insights into antioxidant compensatory mechanisms. Am J Physiol Heart Circ Physiol (2009) 0.80
Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis. Expert Rev Clin Immunol (2012) 0.80
Female sex hormones protect against salt-sensitive hypertension but not essential hypertension. Am J Physiol Regul Integr Comp Physiol (2014) 0.78
Activation of novel estrogen receptor GPER results in inhibition of cardiocyte apoptosis and cardioprotection. Mol Med Rep (2015) 0.76
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science (2005) 6.69
Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science (2003) 6.66
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med (1994) 6.59
The protective effects of estrogen on the cardiovascular system. N Engl J Med (1999) 6.25
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A (2000) 5.47
Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 5.38
Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature (2000) 4.92
Estrogen receptors and human disease. J Clin Invest (2006) 4.91
Molecular and cellular basis of cardiovascular gender differences. Science (2005) 4.37
The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol (2005) 2.89
Direct evidence for S-nitrosation of mitochondrial complex I. Biochem J (2006) 2.88
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res (2006) 2.84
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes. Circ Res (2004) 2.82
Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation (1997) 2.74
Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol (2003) 2.38
Mitochondrial localization of estrogen receptor beta. Proc Natl Acad Sci U S A (2004) 2.15
GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab (2005) 2.12
Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation By electron flow through the respiratory chain complex i. J Biol Chem (1998) 2.01
Transcription factor cross-talk: the estrogen receptor and NF-kappaB. Trends Endocrinol Metab (2005) 1.93
Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res (2005) 1.86
Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol Pharmacol (2005) 1.75
Functional estrogen receptors in the mitochondria of breast cancer cells. Mol Biol Cell (2006) 1.72
Complex actions of sex steroids in adipose tissue, the cardiovascular system, and brain: Insights from basic science and clinical studies. Endocr Rev (2006) 1.68
The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res (2000) 1.55
Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol Heart Circ Physiol (2006) 1.55
Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci U S A (2006) 1.53
False positives in MALDI-TOF detection of ERbeta in mitochondria. Biochem Biophys Res Commun (2006) 1.51
Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol (2005) 1.47
Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor. Proc Natl Acad Sci U S A (1996) 1.45
Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther (2005) 1.44
Diversity in the mechanisms of gene regulation by estrogen receptors. Bioessays (2002) 1.43
Role of the nitric oxide pathway in AMPK-mediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab (2004) 1.40
Estrogen inhibits cardiomyocyte hypertrophy in vitro. Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J Biol Chem (2005) 1.39
Activation of mitochondrial ATP-dependent potassium channels by nitric oxide. Circulation (2000) 1.39
Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2005) 1.24
Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res (1999) 1.24
Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Horm Metab Res (2003) 1.24
Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors. J Biol Chem (2003) 1.22
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol (2007) 1.19
beta-Estradiol, but not alpha-estradiol, reduced myocardial necrosis in rabbits after ischemia and reperfusion. Am Heart J (1996) 1.16
Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circ Res (2003) 1.13
Estrogen and mitochondria: a new paradigm for vascular protection? Mol Interv (2006) 1.13
Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am J Physiol Heart Circ Physiol (2002) 1.13
Hormone replacement therapy and the cardiovascular system lessons learned and unanswered questions. J Am Coll Cardiol (2006) 1.12
Upregulation of mitochondrial respiratory complex IV by estrogen receptor-beta is critical for inhibiting mitochondrial apoptotic signaling and restoring cardiac functions following trauma-hemorrhage. J Mol Cell Cardiol (2006) 1.12
Gender-specific proteomic alterations in glycolytic and mitochondrial pathways in aging monkey hearts. J Mol Cell Cardiol (2004) 1.10
Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol (2005) 1.10
Gender differences in the expression of heat shock proteins: the effect of estrogen. Am J Physiol Heart Circ Physiol (2003) 1.10
Cardioprotective effects of 17 beta-estradiol produced by activation ofmitochondrial ATP-sensitive K(+)Channels in canine hearts. J Mol Cell Cardiol (2000) 1.10
The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med (2004) 1.08
Nongenomic, ER-mediated activation of endothelial nitric oxide synthase: how does it work? What does it mean? Circ Res (2000) 1.07
Activation of estrogen receptor beta is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett (2001) 1.05
Myocardial ischemia-reperfusion injury in estrogen receptor-alpha knockout and wild-type mice. Am J Physiol Heart Circ Physiol (2000) 1.05
Estrogen activates the high-density lipoprotein receptor gene via binding to estrogen response elements and interaction with sterol regulatory element binding protein-1A. Endocrinology (2002) 1.04
Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo. Proc Natl Acad Sci U S A (2006) 1.03
The connexin43 gene is responsive to oestrogen. Proc Biol Sci (1994) 1.01
17Beta-estradiol as a receptor-mediated cardioprotective agent. J Pharmacol Exp Ther (2003) 1.00
Ca(2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2002) 0.99
Inhibition of cardiac PGC-1alpha expression abolishes ERbeta agonist-mediated cardioprotection following trauma-hemorrhage. FASEB J (2006) 0.99
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. Am J Physiol Endocrinol Metab (2002) 0.99
Gender dimorphism in rat liver mitochondrial oxidative metabolism and biogenesis. Am J Physiol Cell Physiol (2005) 0.97
Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol (2003) 0.96
Stressing the obvious? Cell stress and cell stress proteins in cardiovascular disease. Cardiovasc Res (2006) 0.96
Exogenous nitric oxide reduces glucose transporters translocation and lactate production in ischemic myocardium in vivo. Proc Natl Acad Sci U S A (2005) 0.96
Is There a Gender Difference in Infarct Size and Arrhythmias Following Experimental Coronary Occlusion and Reperfusion? J Thromb Thrombolysis (1995) 0.95
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy. Physiol Genomics (2003) 0.95
Estrogen reduces cardiac injury and expression of beta1-adrenoceptor upon ischemic insult in the rat heart. J Pharmacol Exp Ther (2004) 0.93
Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart. J Cardiovasc Pharmacol (2006) 0.93
Connexin 43 signalling and cardioprotection. Heart (2005) 0.93
Gender does not influence acute myocardial infarction in adult dogs. Am Heart J (1995) 0.91
Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. Am J Physiol Heart Circ Physiol (2003) 0.90
Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. J Biol Chem (2004) 0.89
Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism. Am J Cardiol (1998) 0.88
Short-term estrogen reduces myocardial infarct size in oophorectomized female rabbits in a dose-dependent manner. Cardiovasc Drugs Ther (1998) 0.88
Specific regulation of lipocalin-type prostaglandin D synthase in mouse heart by estrogen receptor beta. Mol Endocrinol (2003) 0.86
Effect of NO synthase inhibition on myocardial metabolism during moderate ischemia. Am J Physiol Heart Circ Physiol (2003) 0.82
17beta-estradiol reduces the effect of metabolic inhibition on gap junction intercellular communication in rat cardiomyocytes via the estrogen receptor. J Mol Cell Cardiol (2004) 0.82
Increased glycolytic substrate protection improves ischemic cardiac dysfunction and reduces injury. Am Heart J (2000) 0.81
Gender and post-ischemic recovery of hypertrophied rat hearts. BMC Cardiovasc Disord (2006) 0.81
Dichloroacetate enhanced myocardial functional recovery post-ischemia : ATP and NADH recovery. J Surg Res (1996) 0.80
Estrogen stimulates expression of adenine nucleotide translocator ANT1 messenger RNA in female rat hearts. Mol Cell Endocrinol (1999) 0.80
Estrogen alone or combined with medroxyprogesterone but not raloxifene reduce myocardial infarct size. Eur J Pharmacol (2003) 0.79
Nitric oxide synthase inhibition and elevated endothelin increase oxygen consumption but do not affect glucose and palmitate oxidation in the isolated rat heart. J Physiol Pharmacol (2004) 0.78
Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev (2008) 5.52
Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation (2009) 3.45
Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ Res (2007) 2.97
Hypercontractile female hearts exhibit increased S-nitrosylation of the L-type Ca2+ channel alpha1 subunit and reduced ischemia/reperfusion injury. Circ Res (2006) 2.84
Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res (2002) 2.50
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J (2009) 2.29
Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. J Am Coll Cardiol (2011) 2.15
Nuclear miRNA regulates the mitochondrial genome in the heart. Circ Res (2012) 1.95
Preconditioning: the mitochondrial connection. Annu Rev Physiol (2007) 1.93
Controlled activation of morphogenesis to generate a functional human microvasculature in a synthetic matrix. Blood (2011) 1.91
Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ Res (2004) 1.69
Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling? Free Radic Biol Med (2012) 1.61
Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res (2008) 1.60
Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc Res (2007) 1.57
Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation (2009) 1.56
Cyclophilin D modulates mitochondrial acetylome. Circ Res (2013) 1.53
Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res (2010) 1.48
Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol (2005) 1.47
S-nitrosylation: NO-related redox signaling to protect against oxidative stress. Antioxid Redox Signal (2006) 1.43
Estrogen receptor-beta mediates male-female differences in the development of pressure overload hypertrophy. Am J Physiol Heart Circ Physiol (2004) 1.41
Adenoviral transfer of HIF-1alpha enhances vascular responses to critical limb ischemia in diabetic mice. Proc Natl Acad Sci U S A (2009) 1.41
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol (2008) 1.41
Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res (2010) 1.40
Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol (2011) 1.37
Cardiac-specific ablation of the Na+-Ca2+ exchanger confers protection against ischemia/reperfusion injury. Circ Res (2005) 1.32
G protein-coupled receptor internalization signaling is required for cardioprotection in ischemic preconditioning. Circ Res (2004) 1.27
Mechanisms of erythropoietin-mediated cardioprotection during ischemia-reperfusion injury: role of protein kinase C and phosphatidylinositol 3-kinase signaling. FASEB J (2005) 1.27
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved. J Clin Invest (2011) 1.26
Detection of human CYP2C8, CYP2C9, and CYP2J2 in cardiovascular tissues. Drug Metab Dispos (2007) 1.25
2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology. Cardiovasc Pathol (2011) 1.24
Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci U S A (2011) 1.24
Treatment with an estrogen receptor-beta-selective agonist is cardioprotective. J Mol Cell Cardiol (2007) 1.19
Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem (2011) 1.18
Skeletal muscle ATP kinetics are impaired in frail mice. Age (Dordr) (2013) 1.18
S-nitrosylation: a radical way to protect the heart. J Mol Cell Cardiol (2011) 1.16
The role of beta-adrenergic receptor signaling in cardioprotection. FASEB J (2005) 1.13
Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am J Physiol Heart Circ Physiol (2002) 1.13
Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin Ther Targets (2005) 1.11
Measurement of S-nitrosylation occupancy in the myocardium with cysteine-reactive tandem mass tags: short communication. Circ Res (2012) 1.09
Cardioprotection leads to novel changes in the mitochondrial proteome. Am J Physiol Heart Circ Physiol (2009) 1.07
Expression of activated PKC epsilon (PKC epsilon) protects the ischemic heart, without attenuating ischemic H(+) production. J Mol Cell Cardiol (2002) 1.06
Activation of the prolyl hydroxylase oxygen-sensor results in induction of GLUT1, heme oxygenase-1, and nitric-oxide synthase proteins and confers protection from metabolic inhibition to cardiomyocytes. J Biol Chem (2003) 1.06
Disruption of caveolae blocks ischemic preconditioning-mediated S-nitrosylation of mitochondrial proteins. Antioxid Redox Signal (2011) 1.05
Endothelial expression of hypoxia-inducible factor 1 protects the murine heart and aorta from pressure overload by suppression of TGF-β signaling. Proc Natl Acad Sci U S A (2012) 1.04
Cardioprotection and myocardial reperfusion: pitfalls to clinical application. Circ Res (2013) 1.03
Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol (2002) 1.03
Recurrence of cardiac sarcoidosis in a heart transplant recipient. J Heart Lung Transplant (2005) 1.02
Ischemic preconditioning attenuates mitochondrial localization of PTEN induced by ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2011) 1.00
Ca(2+) loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2002) 0.99
Pivotal role of mTORC2 and involvement of ribosomal protein S6 in cardioprotective signaling. Circ Res (2014) 0.98
Does inhibition of glycogen synthase kinase protect in mice? Circ Res (2008) 0.98
Ion transport and energetics during cell death and protection. Physiology (Bethesda) (2008) 0.95
What makes the mitochondria a killer? Can we condition them to be less destructive? Biochim Biophys Acta (2010) 0.94
A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy. Oncotarget (2012) 0.93
Postconditioning leads to an increase in protein S-nitrosylation. Am J Physiol Heart Circ Physiol (2014) 0.93
Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc Med (2005) 0.92
Nonischemic cardiomyopathy associated with autoimmune polyglandular syndrome type II. Endocr Pract (2007) 0.92
VAMP-1, VAMP-2, and syntaxin-4 regulate ANP release from cardiac myocytes. J Mol Cell Cardiol (2010) 0.91
Male and female mice overexpressing the beta(2)-adrenergic receptor exhibit differences in ischemia/reperfusion injury: role of nitric oxide. Cardiovasc Res (2002) 0.90
Mitochondrial permeability transition pore and calcium handling. Methods Mol Biol (2012) 0.90
Gender differences in sarcoplasmic reticulum calcium loading after isoproterenol. Am J Physiol Heart Circ Physiol (2003) 0.90
Creatine kinase overexpression improves ATP kinetics and contractile function in postischemic myocardium. Am J Physiol Heart Circ Physiol (2012) 0.89
Protein kinase C and preconditioning: role of the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol (2005) 0.88
Hydrogen sulfide [corrected] increases survival during sepsis: protective effect of CHOP inhibition. J Immunol (2014) 0.86
Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging (2013) 0.86
Cause of death and sudden cardiac death after heart transplantation. An autopsy study. Am J Clin Pathol (2003) 0.85
Overexpression of the Na+/H+ exchanger and ischemia-reperfusion injury in the myocardium. Am J Physiol Heart Circ Physiol (2007) 0.85
Integration and regression of implanted engineered human vascular networks during deep wound healing. Stem Cells Transl Med (2013) 0.85
Male/female differences in intracellular Na+ regulation during ischemia/reperfusion in mouse heart. J Mol Cell Cardiol (2004) 0.84
Mechanism of cardioprotection: what can we learn from females? Pediatr Cardiol (2011) 0.80
Acute inhibition of GSK causes mitochondrial remodeling. Am J Physiol Heart Circ Physiol (2012) 0.80
MR proton spectroscopy for myocardial lipid deposition quantification: a quantitative comparison between 1.5T and 3T. J Magn Reson Imaging (2012) 0.80
Preconditioning: is the Akt-ion in the PI3K pathway? J Mol Cell Cardiol (2003) 0.80
Hypertrophy signaling pathways in experimental chronic aortic regurgitation. J Cardiovasc Transl Res (2013) 0.79
Creatine kinase-overexpression improves myocardial energetics, contractile dysfunction and survival in murine doxorubicin cardiotoxicity. PLoS One (2013) 0.79
Estrogen regulation of protein expression and signaling pathways in the heart. Biol Sex Differ (2014) 0.78
Impact of scar, viable myocardium, and epicardial fat on substrate identification of ventricular tachycardia in a case with nonischemic cardiomyopathy. Pacing Clin Electrophysiol (2011) 0.78
Dose dependent effects of cardiac beta2 adrenoceptor gene therapy. J Surg Res (2004) 0.78
Does the voltage dependent anion channel modulate cardiac ischemia-reperfusion injury? Biochim Biophys Acta (2011) 0.77
Sex, drugs, and trial design: sex influences the heart and drug responses. J Clin Invest (2014) 0.77
beta2 adrenoceptor gene therapy ameliorates left ventricular dysfunction following cardiac surgery. Eur J Cardiothorac Surg (2004) 0.77
Heterogeneous distribution of myocardial steatosis--an ex vivo evaluation. Magn Reson Med (2012) 0.77
Effect of p38 MAP kinases on contractility and ischemic injury in intact heart. Acta Physiol Hung (2009) 0.77
Mitochondrial adenine nucleotide transport and cardioprotection. J Mol Cell Cardiol (2011) 0.77
Is Na/Ca exchange during ischemia and reperfusion beneficial or detrimental? Ann N Y Acad Sci (2002) 0.77
Signalosomes: delivering cardioprotective signals from GPCRs to mitochondria. Am J Physiol Heart Circ Physiol (2008) 0.76
Did a classic preconditioning study provide a clue to the identity of the mitochondrial permeability transition pore? Circ Res (2013) 0.76
Extensive cardiac allograft vasculitis and concurrent fat necrosis 6 years after orthotopic heart transplantation. J Heart Lung Transplant (2007) 0.76
Expression and distribution of voltage-gated ion channels in ferret sinoatrial node. Physiol Genomics (2010) 0.76
Hibernating Squirrels: SIRTin Clues for Organ Protection after Ischemia-Reperfusion. Anesthesiology (2016) 0.75
Graft vascular disease after cardiac transplantation and its relationship to mean acute rejection score. Arch Pathol Lab Med (2005) 0.75